Trials / Completed
CompletedNCT00813358
Zenith TX2® Post-market Approval Study
Zenith TX2® TAA Endovascular Graft Post-approval Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- Cook Research Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Zenith TX2® Post-market Approval Study is a clinical trial approved by US FDA to further study the safety and effectiveness of the Zenith TX2® TAA Endovascular Graft in the treatment of thoracic aortic aneurysms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zenith TX2® TAA Endovascular Graft | Endovascular treatment with the study device |
Timeline
- Start date
- 2009-07-10
- Primary completion
- 2020-02-14
- Completion
- 2020-03-23
- First posted
- 2008-12-23
- Last updated
- 2021-06-04
- Results posted
- 2021-05-05
Locations
25 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00813358. Inclusion in this directory is not an endorsement.